Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
- Abstract
Loading... -
+
P1.01-037 - Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival
09:30 - 09:30 | Presenter: Shun Lu | Author(s): Yong Song, Z. Xie, Z. Zhu, Li Liu, Min Li, X. Dong, M. Jin, Jie Hu, C. Rao, G. Tong, D. Zheng, W. Zhao, Y. Chen, H. Han-Zhang, H. Xu, X. Mao, L. Zhang, H. Liu, J. Ye
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-041 - The Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients with T790M Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, X. Zheng, X. Si, Xiaoxia Cui, M. Wang
- Abstract
Loading... -
+
P2.03-050 - The Efficacy of EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Harboring G719X Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, T. Lu, X. Zhang, Xiaoyan Si, M. Wang
- Abstract
Loading...
-
+
MA 11 - Emerging Diagnostic/Biomarkers in NSCLC
- 11:00 - 12:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:M.I. Abdul Wahid, Martin Reck
-
+
MA 11.07 - Exosomes-Transmitted MicroRNAs Promote EGFR-TKIs Resistance in NSCLC by Activating PI3K/AKT Signaling Pathway
11:40 - 11:45 | Presenter: Xiaozhen Liu | Author(s): Tao Jiang, X. Li, J. Li, L. Zhang, S. Zhao, Y. Jia, Jinpeng Shi, C. Zhao, M. Qiao, Fei Zhou, J. Zhao, Caicun Zhou
- Abstract
Loading...
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-087 - Impact Factor Analysis for Efficacy and Prognosis of Anlotinib in NSCLC as Third-Line Treatment: Data from Trial ALTER 0303
09:30 - 09:30 | Presenter: Kai Li | Author(s): J. Wang, Baohui Han, Y.Z. Zhao, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, J. Dong, B. Li, Y. Chen, J. Zhou, D. Wang, X. Zhou, Y. Yu, L. Chen, A. Liu, J. Huang, C. Huang, B. Cao, J. Chen, R. Ma, Z. Yu, C. Ding, H. Wang
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-006 - Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): K. Li, Q. Wang, Y.Z. Zhao, L. Zhang, J. Shi, Z. Wang, Ying Cheng, J. He, S. Yuankai, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, B. Li
- Abstract
Loading... -
+
P3.03-017 - Blood Samples NGS for Baseline Molecular Signature of Anotinib Treated Advanced NSCLC Patients in ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): Y.Z. Zhao, K. Li, J. Wang, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan
- Abstract
Loading...
-
+
OA 16 - Treatment Strategies and Follow Up
- 14:30 - 16:15
- 10/18/2017
- Location: Room 315
- Type: Oral
- Track: Early Stage NSCLC
- Moderators:Jun Nakajima, T. Demmy
-
+
OA 16.04 - Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
15:00 - 15:10 | Presenter: Dongsheng Yue | Author(s): S. Xu, Q. Wang, X. Li, Y. Shen, H. Zhao, C. Chen, W. Mao, W. Liu, J. Liu, L. Zhang, H. Ma, Q. Li, Y. Yang, Y. Liu, H. Chen, C. Wang
- Abstract
Loading...